Castellan Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-14,948
Closed -$2.32M 65
2023
Q1
$2.32M Buy
14,948
+1,885
+14% +$304K 1.58% 36
2022
Q4
$2.31M Buy
13,063
+185
+1% +$31.9K 1.61% 34
2022
Q3
$2.1M Buy
12,878
+40
+0.3% +$6.77K 1.64% 29
2022
Q2
$2.28M Buy
12,838
+1,595
+14% +$284K 1.81% 23
2022
Q1
$1.99M Buy
11,243
+932
+9% +$159K 1.38% 35
2021
Q4
$1.76M Buy
10,311
+1,211
+13% +$198K 1.22% 36
2021
Q3
$1.47M Sell
9,100
-1,800
-17% -$307K 0.76% 52
2021
Q2
$1.8M Buy
10,900
+1,000
+10% +$166K 0.75% 38
2021
Q1
$1.63M Buy
9,900
+2,400
+32% +$388K 0.87% 30
2020
Q4
$1.18M Buy
+7,500
New +$1.11M 1.27% 36

Other funds holding JNJ

Castellan Group's JNJ Position: Q2 2023 in Review

Castellan Group sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 14,948 shares — an estimated $2.32M sold.

Castellan Group first reported a position in JNJ in Q4 2020 and held it in 10 quarters. The position peaked at $2.32M in Q1 2023. 3,751 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • Castellan Group reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
  • Castellan Group sold 14,948 Johnson & Johnson shares in Q2 2023, an estimated $2.32M.
  • Castellan Group first reported a position in Johnson & Johnson in Q4 2020 and held it in 10 quarters.
  • Castellan Group's Johnson & Johnson position peaked at $2.32M in Q1 2023.
  • 3,751 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Castellan Group's 13F filing for Q2 2023, filed 14 Aug 2023.